New Zealand markets closed

Apollo Tactical Income Fund Inc. (AIF)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
14.57-0.09 (-0.61%)
At close: 04:00PM EDT
14.49 -0.08 (-0.55%)
After hours: 05:16PM EDT
Full screen
Loading interactive chart…
  • GlobeNewswire

    Apollo Tactical Income Fund Inc. Declares May 2024 Monthly Distribution of $0.144 Per Share

    NEW YORK, May 10, 2024 (GLOBE NEWSWIRE) -- (NYSE: AIF) - Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of May 2024 of $0.144 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: May 22, 2024Record Date: May 23, 2024Payment Date: May 31, 2024Per Share Amount: $0.144 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Relations Man

  • GlobeNewswire

    MidCap Financial Investment Corporation Reports Financial Results for the Quarter Ended March 31, 2024

    Results for the Quarter Ended March 31, 2024 and Other Recent Highlights: Net investment income per share for the quarter was $0.44, compared to $0.46 for the quarter ended December 31, 2023 Net asset value per share as of the end of the quarter was $15.42, compared to $15.41 as of December 31, 2023 New investment commitments made during the quarter totaled $149 million(1) Gross fundings, excluding revolver fundings(2), totaled $129 million for the quarter Net fundings, including revolvers(2), t

  • GlobeNewswire

    Apollo Tactical Income Fund Inc. Declares April 2024 Monthly Distribution of $0.144 Per Share

    NEW YORK, April 12, 2024 (GLOBE NEWSWIRE) -- (NYSE: AIF) - Apollo Tactical Income Fund Inc. (the “Fund”) today announced the declaration of its distribution for the month of April 2024 of $0.144 per common share, payable on the date noted below. The following dates apply to the declared distribution: Ex-Date: April 22, 2024Record Date: April 23, 2024Payment Date: April 30, 2024Per Share Amount: $0.144 Apollo Contact Information: Product Literature877-864-4834 InvestorsElizabeth BesenInvestor Rel